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Andreas Gruentzig — the life and death of a pioneer
The history of cardiology is rich
with pioneers whose contributions pa-
ved the way to the advancement of in-
vasive cardiology, but not all of them
have been recognized and appreciated
for their innovations and accomplish-
ments. The late Andreas Gruentzig
was a pioneer, who was acclaimed even
in his lifetime, as were Forssmann,
Cournand and Richards, who were even
crowned by the Nobel Prize Commit-
tee. There were many other pioneers
whose contributions are less recognized in history,
like Otto Klein of Prague, while other outstanding cli-
nicians whose contributions were widely known even
during their life time, but in retrospect it seems that
unfortunately did not receive enough official recogni-
tion as in the case of Charles T. Dotter and Mason
Sones. The ground breaking contribution of Andreas
Gruentzig: his life; his work; and his tragic death, are
the subject of this article.
Andreas Roland Gruentzig was born in Dres-
den, Germany in 1939 and following WWII he was
taken as a child by an uncle to Argentina, later re-
turning to Leipzig, Germany. In 1957 he crossed
through Berlin to Heidelberg in the West and in
1964 he graduated medical school. Becoming a fel-
low of the University Hospital in Zurich in 1969
Andreas took up angiology, which at that time was
a sub-speciality of internal medicine. From the
Angiology Department, headed by Dr. Bollinger, he
continued to Radiology, headed by Dr. Wellauer.
Working in this department, Andreas happened to
visit Dr. Eberhard Zeitler [1] and observed a pro-
cedure of peripheral artery “angioplasty” using the
“Dotter Method” [2]. Even though this particular
procedure was unsuccessful, he felt confident eno-
ugh to start performing intravascular angioplasties
on selected patients. In 1974 Gruentzig’s commen-
ced his formal training in cardiology in the Depart-
ment of Cardiology headed by Hans Peter Krayen-
buhl and Wilhelm Rutishauser.
The innovation of placing a latex
balloon in an angiographic catheter be-
longs to Dr. Portman, and this trigge-
red Dr. Gruentzig to use this method
to dilate a constricted coronary artery.
It took Andreas two years to solve “mi-
nor” technical problems from  conce-
iving his idea till its true application. It
is now legendary that Gruentzig wor-
ked, together with his wife Michaela,
his assistant Maria Schlumpf and her
husband Walter, in the family kitchen
in the evenings trying many versions of the balloon
catheter. The preparations included, among other
things, cooperation with factories, chemists and
many other technical experts. After hundreds of
experiments, Gruentzig was satisfied with the tech-
nical details of the catheter and having also solved
the problem of the “double lumen catheter”, he felt
that the time was ripe for its use in humans as well.
January 23, 1975 was the date of the first suc-
cessful use of a double lumen catheter in a patient’s
iliac artery. Then back in the “kitchen”, it took ano-
ther 6 months till Gruentzig was satisfied that his
catheter was small and safe enough to be induced
into the coronary arteries of dogs. In November,
1976 at the Scientific Sessions of the American
Heart Association, Dr. Gruentzig presented his
animal experiments in a poster session [3]. Here
started the friendship and the scientific collabora-
tion between Andreas and Dr. Richard Myler of San
Francisco which resulted in several intra-operati-
ve balloon dilatations of coronary arteries during
May, 1977 at St. Mary’s Hospital, San Francisco.
Gruentzig’s aim of course was to dilate an ob-
structed coronary artery on the catheterization ta-
ble in a patient while he/she is awake. The search
for a suitable patient, who was defined as one with
a single vessel disease and good left ventricular
function went on for several months, both in San
Francisco and Zurich. Finally, and surprisingly, the
patient who voluntarily agreed to this trial method
349
Shlomo Stern, Andreas Gruentzig — the life and death of a pioneer
www.fc.viamedica.pl
was found in Zurich. Gruentzig back in Switzerland,
met the patient, a 38 year old insurance salesman,
who suffered from severe angina, had a positive
exercise test and in whom a severe proximal left
anterior descending stenosis with good left ventri-
cular function was found.  A relatively short conver-
sation between the patient and Dr. Gruentzig se-
emed to satisfy the ethical aspect of his consent,
let us remember this was the year of 1977.
Dr. Bernhard Meier, himself a resident physician at
that time, witnessed the act of obtaining the “infor-
med consent” from the patient for the first ever co-
ronary dilatation procedure. Later, Dr. Meier called
the patient’s eager consent to Dr. Gruentzig’s pro-
posal “a lucky thing for the future of angioplasty” [4].
Dr. Gruentzig performed on this patient the
first PTCA in a cath lab in Zurich Switzerland on
September 16, 1997. As this patient became angi-
na free immediately after the procedure and rema-
ined so for several weeks (and as a matter of fact,
even 10 years later, when he was recatheterized at
Emory Hospital in Atlanta, the artery dilated
10 years earlier, was found to be open, without re-
stenosis) Dr. Gruentzig felt it proper to publish this
case,  with the other 4 “first” ones in Lancet [5].
His first cases were also presented in Miami Be-
ach at the American Heart Association’s Scientific
Sessions [6]. The writer of this article, who was at
this meeting presenting his own paper, remembers
how Dr. Gruentzig’s lecture was immediately ac-
cepted by the enthusiasticly applauding audience as
a breakthrough communication.
Looking back 40 years later, it is amazing to
see the immediate huge interest in this procedure
in the U.S. and the lack of enthusiasm on this side
of the Atlantic Ocean. A certain “conservatism”
which prevailed in European Medicine after WWII,
a reluctance to accept the performance of a thoro-
ughly invasive technique by a non-surgeon and
maybe a lack of self-confidence by European car-
diologists to perform a procedure which requires
cardiac surgeons to stand-by, could all have played
a part in the slow progress in performing PTCA’s
in Europe. In the U.S., early co-workers and friends
of Andreas Gruentzig such as Richard Myler, Simon
Stertzer were excited about the success of the ca-
ses performed in Zurich and in March, 1978 they
performed nearly simultaneously in San Francisco
and New York the first American cath lab PTCA’s.
In the U.S. balloon dilatations for coronary ar-
tery disease spread like bush fire. Between 1978–
1980  PTCA’s were performed in tens of Hospitals
on hundreds of patients — and mostly successfully.
Meanwhile Gruentzig made all the efforts to keep
Zurich as the world center of PTCA’s, by organi-
zing there courses to teach his methods, but he was
frustrated by the limitations his superiors placed on
him in further developing “coronary angioplasty”,
and by the relatively slow spread of PTCA’s in Eu-
rope. It is therefore easy to understand that he co-
uldn’t resist an invitation from Atlanta’s Emory
Hospital to resettle there, as Director of Interven-
tional Cardiology and full professor. Dr. King de-
scribed [7] Andreas’s hesitations before he decided
to make this leap, yet he became convinced that wor-
king in America will promote his method and will
influence centers all over the world to adopt PTCA,
which, he knew was his life’s true achievement.
Andreas Gruentzig’s career in the US was
extremely successful. Emory became a leading cen-
ter of PTCA’s in America, and at the same time
several important advancement’s using the ballo-
on procedure, were made in other centers in the
U.S. and Europe as well. Shortly angioplasty has
been used in patients with acute myocardial infarc-
tion as pioneered by Meier et al. [8], and multi-ves-
sel disease also became soon amenable with angio-
plasty, as shown by Hartzler et al. [9], all these pa-
rallel with technical improvements in the catheters
and balloons used. At Emory, between 1980–1985
the team, headed by Drs. Gruentzig, King and Do-
uglas, performed over 5,000 PTCA’s and spread the
knowledge by organizing 10 angioplasty courses for
American and overseas cardiologists.
A terrible tragedy and loss is the only way to
describe the fate of Andreas Gruentzig. On Octo-
ber 27, 1985, at a time which could be seen as
a zenith in his career, he was piloting his twin-en-
gine plane between his two homes in Atlanta and
Sea Island when over Monroe County, in an une-
xpected storm, the plane crashed. Andreas and his
second wife Margareth Ann, were instantly killed.
Andreas is survived by his only daughter.
Even so, Andreas Gruentzig could see that
even during his cut-short life, his dream came true.
He must have been aware of the great appreciation
and admiration of his colleagues the cardiologists,
of the whole medical establishment, and last but not
least, of grateful patients who owed their improved
quality of life and frequently even their life, to his
unique pioneering achievements. After his death,
Emory’s Cardiovascular Center and several other in-
terventional laboratories in the world carry Gruent-
zig’s name, the International Andreas Gruentzig So-
ciety, launched in 1990, carries the torch for cardiac
and vascular interventions, Fellowships on his name
and many endeavors serve the noble aim of preserving
Andreas Gruentzig’s memory and heritage.
Be this article a small token for his enormous
achievements.
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